Skip to main content
Department of Biochemistry and Molecular Medicine

Department of Biochemistry and Molecular Medicine

News releases

November 2015arrow

UC Davis researchers find success in tele-audiology program

November 24, 2015

Researchers at UC Davis have shown that the California Tele-Audiology Program (CTP), which provides follow-up diagnostic evaluations for infants who did not pass their initial newborn hearing test, dramatically improves access to audiologists. [en español]

Common pigeon: Not just a bird brain, but a brainy bird

November 18, 2015

If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study from researchers at the University of California, Davis and The University of Iowa has found.

Lam receives $4 million in NIH grants for novel cancer research

November 18, 2015

Kit Lam, professor and chair of the Department of Biochemistry and Molecular Medicine, has been awarded two major, multi-disciplinary U01 grants from the National Institutes of Health (NIH), the first to investigate use of a new tool to visualize cancer tumor growth and response to nanoparticle drugs, and the other to develop a new 4-D imaging tool to advance the understanding of how the nucleus functions in living cells.

Small RNA has big impact on prostate cancer

November 17, 2015

Researchers at the UC Davis Comprehensive Cancer Center have shown that the microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer.

Statewide cancer report finds significant disparities in outcomes, quality of care by insurer

November 5, 2015

A new report by the UC Davis Institute for Population Health Improvement (IPHI) comparing quality of care and outcomes for breast, colon, rectal, lung and prostate cancers according to source of health insurance coverage has identified substantial disparities in stage of diagnosis, providers’ use of recommended treatment and survival rates.

New technology will help define the environmental triggers of childhood asthma

November 4, 2015

UC Davis researchers have received a four-year, $1.5 million grant from the National Institutes of Health to develop a small, wearable sensor that can measure the relationship between environmental exposures and pediatric asthma.

October 2015arrow

MIND Institute offers program for adults with autism spectrum disorder

October 29, 2015

Researchers with the Behavioral Health Center of Excellence and MIND Institute at UC Davis are seeking adult participants, aged 18 to 38 years and diagnosed with or suspected of having autism or Asperger’s disorder, to participate in a research study, the ACCESS Program (Acquiring Career, Coping, Executive-Function and Social Skills Program).

Menopausal status a better indicator than age for mammography frequency

October 20, 2015

In a study conducted to inform American Cancer Society breast cancer screening guidelines, UC Davis researcher Diana L. Miglioretti reports a screening mammogram once every two years is safe for postmenopausal women at average risk of breast cancer.

Bilingual website boosts awareness of kidney transplantation and donation among Hispanics/Latinos

October 7, 2015

A new bilingual website sensitive to Hispanic/Latino cultural needs increases knowledge about living kidney donation and transplantation beyond standard education provided by transplant centers, a new study published Oct. 7 in the journal Transplantation has found. [en español]

UC Davis granted $15.5 million to build world's first total-body PET scanner

October 6, 2015

A UC Davis research team has been awarded $15.5 million to build the world’s first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation’s leading edge of molecular imaging.

September 2015arrow

New treatments a big step for patients with advanced kidney cancer

September 29, 2015

In an editorial published in the New England Journal of Medicine, Primo Lara, associate director for Translational Research at the UC Davis Comprehensive Cancer Center and David Quinn, medical director, USC Norris Cancer Hospital, highlight two new drugs that have shown great efficacy against kidney cancer.

UC Davis researcher advocates ending Medicare coverage of controversial mammography tool

September 28, 2015

A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues Joshua Fenton, a family physician and comparative effectiveness researcher in an editorial published online today in the Journal of the American Medical Association Internal Medicine.

UC Davis to test a computer program designed to reduce suicide

September 25, 2015

UC Davis Health System researchers have received a four-year, $1.3 million grant from the U.S. Centers for Disease Control and Prevention (CDC) to use a technology-based approach to help prevent suicide among those most at risk: middle-aged men.

Tumor suppressor LRIG1 controls breast cancer aggression and invasion

September 21, 2015

Researchers at UC Davis have shown that the protein LRIG1 reduces breast cancer invasion and could potentially help control metastasis. Using aggressive basal-like breast cancer cell lines, the scientists found that restoring LRIG1 expression reduced these cells’ growth and invasiveness.

UC Davis MIND Institute studies the use of sertaline (Zoloft ®) in young children with autism spectrum disorder

September 18, 2015

Whether the language and social development of very young children with ASD can be improved through treatment with sertraline, commonly known by the brand name Zoloft ®, is the subject of a new clinical trial at the UC Davis MIND Institute.

Cancer Center joins collaborative molecular oncology intiative

September 15, 2015

The UC Davis Comprehensive Cancer Center has joined a unique new collaboration to accelerate the development of precision cancer treatment through the collection and sharing of genomics data

Low vitamin D among the elderly is associated with significant decline in cognition, dementia

September 14, 2015

Vitamin D insufficiency among the elderly is highly correlated with accelerated cognitive decline and impaired performance, particularly in domains such as memory loss that are associated with Alzheimer’s disease and dementia, researchers with the UC Davis Alzheimer’s Disease Center and Rutgers University have found. [en español] [中文 Chinese]

UC Davis study shows popular molecular tests over diagnose C. difficile infections up to 50 percent

September 8, 2015

Clostridium difficile is a common cause of infection and diarrhea in hospitalized patients, but a new study by UC Davis pathologists suggests that many patients are mistakenly diagnosed and do not need antibiotic treatment.